Evaluation of T cell responses with the QuantiFERON SARS-CoV-2 assay in individuals with 3 doses of BNT162b2 vaccine, SARS-CoV-2 infection, or hybrid immunity

Targets of T Cell Responses to SARS-CoV-2 Coronavirus in Humans with COVID-19 Disease and Unexposed Individuals

Alba Grifoni, Daniela Weiskopf, Sydney I. Ramirez et al. · Cell · 2020 · 4K citations · Full text

Viral Persistence, T Cell Responses, Sars-cov-2 Coronavirus +8

Robust T Cell Immunity in Convalescent Individuals with Asymptomatic or Mild COVID-19

Takuya Sekine, André Perez‐Potti, Olga Rivera‐Ballesteros et al. · Cell · 2020 · 2K citations · Full text

Early induction of functional SARS-CoV-2-specific T cells associates with rapid viral clearance and mild disease in COVID-19 patients

Anthony T. Tan, Martin Linster, Chee Wah Tan et al. · Cell Reports · 2021 · 785 citations · Full text

Impact of SARS-CoV-2 variants on the total CD4+ and CD8+ T cell reactivity in infected or vaccinated individuals

Alison Tarke, John Sidney, Nils Methot et al. · Cell Reports Medicine · 2021 · 665 citations · Full text

Memory T cell responses targeting the SARS coronavirus persist up to 11 years post-infection

Oi-Wing Ng, Adeline Chia, Anthony T. Tan et al. · Vaccine · 2016 · 486 citations · Full text

Viral Persistence, Immunology, Cd4 T Cell Responses +6